Xijing Hospital: Ischemic Stroke trials

The registry lists 17 Ischemic Stroke studies with Xijing Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 3Phase 4 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Early Neurovascular Decoupling Trajectories After Revascularization in Acute Ischemic StrokeRecruitingNCT07405762
• Exploration and Establishment of an Early Warning System for Futile Reperfusion - A I SEnrolling by invitationNCT07045987
• Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic StrokeRecruitingNCT06639360Not applicable
• Antithrombotic Drug Use in Patients With Ischemic Stroke and MicrobleedsRecruitingNCT05032053
• Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)Active, not recruitingNCT05512910Phase 4
• Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous ThrombectomyCompletedNCT05487417Phase 4
• Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic StrokeStatus unknownNCT05282290Not applicable
• Predictive Study of Serum Endocan for Hemorrhagic Transformation After Reperfusion Therapies in Acute Ischemic StrokeStatus unknownNCT05228080
• Low-dose Aspirin Therapy in Patients With Ischemic Stroke and MicrobleedsStatus unknownNCT04504864Phase 4
• The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation.Status unknownNCT02181374
• Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular EventsStatus unknownNCT01924325Phase 2/3
• Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular EventsStatus unknownNCT01923818Phase 2/3
• Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral InfarctionStatus unknownNCT01851759Phase 2
• Mildronate for Acute Ischemic StrokeCompletedNCT01831011Phase 2
• Efficacy and Safety of Mildronate for Acute Ischemic StrokeStatus unknownNCT01800357Phase 2
• Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic StrokeCompletedNCT00815763Phase 3
• Ginsenoside-Rd for Acute Ischemic StrokeCompletedNCT00591084Phase 2